Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01724632 · ClinicalTrials.gov registry record · NA

LIVE SMART: Smartphone Intervention for Weight Control

A NA study, sponsored by The Miriam Hospital.

Completed
Registry status
NA
Development phase
276
Enrollment target

NCT01724632: Completed NA study, sponsored by The Miriam Hospital.

NCT01724632 is a NA study that has completed, run by The Miriam Hospital. The registered enrollment target is 276 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (80% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01724632, a NA study, has completed, sponsored by The Miriam Hospital.

COMPLETED
Registry status
NA
Development phase
276 participants
Enrollment target

Study Summary

The purpose of this study is to compare three methods of delivering behavioral weight loss treatment.Participants are randomly assigned to one of three 18-month weight loss treatments (group, individual, or smartphone treatment). Participants who are assigned to group treatment will attend group meetings weekly for the first 6 months, then every 2 weeks for 6 months, and then monthly for the final 6 months. Participants who are assigned to individual treatment will attend one-on-one sessions with a weight loss counselor every month for 18 months. Participants who are assigned to smartphone treatment will use a smartphone to learn and practice weight loss skills. They will also attend one-on-one sessions with a weight loss counselor every month for 18 months. Assessment visits are conducted at baseline, 6, 12, and 18 months.

Interventions

  • BEHAVIORAL Lifestyle Counseling

Trial Details

FieldValue
Enrollment Target 276 participants
Start Date 2012-11
Est. Completion 2016-08
Phase NA
The Miriam Hospital

136 total trials

What the finished NCT01724632 record still lists

NCT01724632 is an interventional study that assigns participants to a tested intervention. The registered 276 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (80% lower).

The record links to 0 conditions, and to 1 intervention - of which Lifestyle Counseling is the first listed.

NCT01724632 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01724632 about?

NCT01724632 is a clinical study titled "LIVE SMART: Smartphone Intervention for Weight Control". The purpose of this study is to compare three methods of delivering behavioral weight loss treatment.Participants are randomly assigned to one of three 18-month weight loss treatments (group, individual, or smartphone treatment). Participants who are assigned to group treatment will attend group mee...

What is the current status of trial NCT01724632?

This trial is currently completed. It is a NA study. The enrollment target is 276 participants. The study started on 2012-11. Estimated completion is 2016-08.

What interventions are being tested in trial NCT01724632?

The interventions under investigation include: Lifestyle Counseling (BEHAVIORAL).

Who is sponsoring clinical trial NCT01724632?

This trial is sponsored by The Miriam Hospital, which has 136 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01724632's enrollment target sits among peer trials

276 383rd of 2000 higher than 1,618 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01371630 · 276 participants · Phase 1

    Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia

  • NCT04192344 · 276 participants · Phase 1

    A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-021 in Patients With Advanced Solid Tumor

  • NCT05294991 · 276 participants · NA

    Wellness App for Sleep Disturbance in Hematological Cancer Patients

  • NCT05610852 · 276 participants · NA

    Single-Port Transvesical Partial Prostatectomy Versus High Intensity Focused Ultrasound

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01724632, the US trial registry maintained by the National Library of Medicine. NCT01724632 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.